- Details
This study adds to the growing body of literature that suggests natamycin may be more effective for treating fungal keratitis than voriconazole.
- Details
Ophthotech announced that Genentech will join Novartis and split rights to pegpleranib (Fovista) for the treatment of wet AMD.
- Details
Allergan announced that its biodegradable sustained-release bimatoprost implant is comparable to daily topical bimatoprost.
Read more: Positive results for sustained-release bimatoprost implant
- Details
The U.S. FDA has granted orphan drug designation to AGTC’s gene therapy product candidate for the treatment of achromatopsia caused by mutations in the CNGA3 gene.
- Details
A randomized trial from DRCR.net has shown ranibizumab is as effective as panretinal photocoagulation in treating PDR, and better than laser in preserving patients’ peripheral and night vision.
- Details
Long-term response to anti-VEGF therapy in DME may be predicted after 3 injections at 12 weeks
Read more: Long-term response to anti-VEGF therapy for DME can be predicted by 12 Weeks